ID,author,year,cancerType,cellLine,time,coumarin,coumarinDose,viability,viabilitySD,viabilityN,control,controlSD,controlN
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,16.7,93.61,6.39,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,33.4,85.81,2.13,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,66.8,78.95,8.04,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,133.6,52,11.35,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,16.7,92.67,4.49,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,33.4,79.9,5.2,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,66.8,53.19,4.49,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,133.6,37.58,5.91,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,16.7,97.87,1.42,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,33.4,91.48,6.62,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,66.8,60.04,14.19,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,133.6,44.2,5.44,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,16.7,84.86,5.21,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,33.4,69.97,4.26,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,66.8,65.01,6.43,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,133.6,43.26,3.54,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,16.7,74.94,11.34,3,92.9,7.1,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,33.4,72.1,10.16,3,92.9,7.1,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,66.8,69.97,6.43,3,92.9,7.1,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,133.6,41.13,5.67,3,92.9,7.1,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,31.49,50,5.83,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,47.93,50,5.83,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,3.13,88.38,6.36,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,6.25,82.32,2.38,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,12.5,71.21,5.57,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,25,55.34,6.1,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,50,41.59,3.44,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,100,22.53,0.79,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,3.13,88.35,11.65,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,6.25,85.44,7.41,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,12.5,72.25,19.84,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,25,69.04,5.03,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,50,64.28,9.26,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,100,18.78,3.45,3,100,3.36,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,5,93.33,8.23,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,10,94.5,4.7,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,20,92.15,6.66,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,40,85.88,4.7,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,80,65.88,6.27,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,5,93.72,3.92,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,10,85.88,7.84,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,20,83.13,7.05,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,40,76.86,10.19,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,80,64.31,8.23,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,5,92.94,7.84,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,10,85.49,10.19,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,20,81.56,3.13,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,40,78.43,6.27,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,80,49.41,1.96,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,5,86.66,3.92,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,10,81.17,8.62,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,20,77.64,3.13,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,40,73.72,5.88,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,80,42.35,4.31,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,5,79.6,4.7,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,10,76.47,8.23,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,20,73.72,3.13,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,40,70.58,5.09,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,80,34.9,5.88,3,77.25,6.66,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,16.7,99.25,4.32,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,33.5,100.37,2.47,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,67,99.04,3.7,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,134,97.71,3.09,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,16.7,103.91,2.47,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,33.5,96.98,3.09,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,67,84.53,3.7,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,134,76.37,4.34,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,16.7,105.6,9.87,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,33.5,102.49,10.49,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,67,87.02,4.32,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,134,75.27,8.02,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,16.7,80.24,7.95,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,33.5,78.18,6.43,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,67,62.05,4.28,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,134,45.63,6.42,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,16.7,91.8,3.67,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,33.5,82.35,1.83,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,67,60.04,9.48,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,134,47.54,6.12,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,16.7,88.86,1.83,3,88.2,3.67,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,33.5,78.25,6.41,3,88.2,3.67,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,67,56.34,7.95,3,88.2,3.67,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,134,40.24,1.83,3,88.2,3.67,3
46,Afshari et al.,2019,Glioblastoma,U87,8,Auraptene,167.6,70.16,2.76,3,100,1.65,3
46,Afshari et al.,2019,Glioblastoma,U87,8,Auraptene,335.2,51.93,3.31,3,100,1.65,3
46,Afshari et al.,2019,Glioblastoma,U87,24,Auraptene,167.6,57.91,3.34,3,100,2.09,3
46,Afshari et al.,2019,Glioblastoma,U87,24,Auraptene,335.2,42.5,2.91,3,100,2.09,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,2.5,90.94,4.53,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,5,86.41,4.53,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,10,75.09,7.55,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,20,55.09,16.6,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,40,28.3,2.26,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,2.5,86.41,9.43,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,5,84.9,19.62,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,10,70.18,19.63,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,20,56.6,3.77,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,40,45.66,17.35,3,100,9.05,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,12.5,92.84,13.58,3,100,2.91,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,25,80.73,9.91,3,100,2.91,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,50,48.44,6.23,3,100,2.91,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,100,42.2,4.03,3,100,2.91,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,12.5,108.62,21.65,3,100,6.6,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,25,109.35,13.21,3,100,6.6,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,50,67.88,14.68,3,100,6.6,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,100,35.59,3.67,3,100,6.6,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,12.5,66.42,15.78,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,25,44.77,10.27,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,50,29.35,1.47,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,100,29.72,1.1,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,12.5,86.97,3.3,3,100,8.07,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,25,84.4,4.4,3,100,8.07,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,50,48.44,3.67,3,100,8.07,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,100,44.03,4.41,3,100,8.07,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,1,89.04,6.18,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,2,98.87,10.68,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,5,100.28,10.67,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,10,68.25,8.99,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,15,25.28,5.33,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,20,18.82,3.93,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,25,15.73,1.96,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,30,15.16,2.53,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,40,16.57,1.96,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,50,17.97,2.53,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,1,107.26,4.93,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,2,106.84,6.17,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,5,95.75,4.11,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,10,96.98,6.99,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,15,76.84,4.11,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,20,74.79,5.34,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,25,65.34,5.75,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,30,56.71,5.34,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,40,51.78,4.52,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,50,51.36,5.35,3,100,3.36,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,48,Auraptene,10,98.62,1.83,3,99.9,1.76,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,48,Auraptene,20,100,4.3,3,99.9,1.76,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,10,97.8,1.74,3,99.4,1.51,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,20,95.7,4.3,3,99.4,1.51,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,40,79.2,10.7,3,99.4,1.51,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,10,81.2,15.58,3,98.9,2.01,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,20,87.3,3.52,3,98.9,2.01,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,40,76,11.61,3,98.9,2.01,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,1,90.2,2.45,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,3,88.73,4.9,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,10,78.93,3.93,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,30,52.46,2.46,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,1,87.09,1.44,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,3,84.22,1.44,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,10,57.9,2.87,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,30,19.14,1.43,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,1,99.53,3.3,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,3,100,2.8,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,10,98.12,2.82,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,30,87.74,1.89,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,144,Auraptene,30,71,0.5,3,100,3.36,3
59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,61.3,50,3.65,3,100,3.36,3
59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,103.8,75,4.79,3,100,3.36,3
59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,207.7,49.24,2.52,3,100,3.36,3
60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,12.25,81.44,6.09,6,100,3.36,6
60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,25,75.34,5.54,6,100,3.36,6
60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,50,62.04,5.81,6,100,3.36,6
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,70,50,6.82,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MDA-MB231,48,Auraptene,60,50,6.82,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,0.1,103.26,12.76,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,1,99.11,7.12,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,10,89.91,6.23,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,50,70.91,4.75,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,100,26.11,6.82,2,100,3.36,2
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,12.5,105.25,3.94,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,25,106.37,8.45,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,50,84.99,5.34,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,100,75.42,2.53,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,12.5,80.44,1.59,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,25,61.85,1.86,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,50,50.7,1.86,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,100,38.76,1.59,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,12.5,76.01,1.75,3,100,2.04,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,25,59.12,2.91,3,100,2.04,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,50,46.89,3.2,3,100,2.04,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,100,42.52,5.53,3,100,2.04,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,15,99.68,2.02,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,30,80.42,7.84,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,60,63.39,3.36,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,90,60.48,2.91,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,120,43.68,2.46,3,100,3.36,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,15,87.81,3.59,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,30,79.3,1.57,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,60,70.34,1.56,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,90,62.72,3.36,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,120,57.34,2.24,3,100,2.24,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,15,72.04,2.31,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,30,60.21,3.58,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,60,56.45,2.33,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,90,41.03,2.28,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,120,33.15,5.02,3,100,2.8,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,40,89.38,11.02,3,100,3.36,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,80,80.81,2.04,3,100,3.36,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,160,77.55,2.45,3,100,3.36,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,330,46.53,2.45,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,6.25,94.44,2.96,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,12.5,92.59,1.48,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,25,87.03,3.34,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,50,84.07,2.59,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,100,58.14,2.6,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,200,41.48,1.48,3,100,3.36,3